Evidence map›Paper›PMID 41507512›Full record

ArticleAAPS PharmSciTech2026

Development of Diclofenac Acid Encapsulated Transferosomal gel with Enhanced Antioxidant and Anti-Inflammatory Activities for the Management of Musculoskeletal Pain.

Subhrasima Nayak, Arka Karmakar, Sampada Shinde, Lalit Kumar

Abstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Subhrasima NayakDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Vaishali, Hajipur, Bihar, 844102, India.ORCID http://orcid.org/0009-0002-5111-9821
Arka KarmakarDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Vaishali, Hajipur, Bihar, 844102, India.ORCID http://orcid.org/0000-0003-3446-7699
Sampada ShindeDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Vaishali, Hajipur, Bihar, 844102, India.ORCID http://orcid.org/0009-0003-8845-7215
Lalit KumarDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research, Vaishali, Hajipur, Bihar, 844102, India. lalit.kumar@niperhajipur.ac.in.ORCID http://orcid.org/0000-0002-2418-9712

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myopathies, joint impairment, muscle spasm, and torn muscles cause an excessive amount of musculoskeletal inflammation, which ultimately causes muscular soreness and stiffness, leading to difficulty in mobility. NSAIDs can suppress the COX enzyme, crucial for converting arachidonic acid into prostaglandin-E

Indexed as

Anti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAntioxidantsDiclofenacLiposomesMusculoskeletal PainAnimalsChemistry, PharmaceuticalDrug CarriersDrug LiberationGelsHumansParticle SizeSolubilityAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAntioxidantsDiclofenacDrug CarriersGelsLiposomesanti-oxidant activitycellular antiinflammatorydiclofenac acidex vivo permeationHaCat cellsmusculoskeletal inflammation

Identifiers

PMID41507512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.